Cargando…
In Vitro Comparative Cytotoxicity Assessment of Sclerosants Used for Venous Malformations
Autores principales: | Moriwaki, Yuta, Kurita, Masakazu, Hongo, Hiroki, Okazaki, Mutsumi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8448005/ https://www.ncbi.nlm.nih.gov/pubmed/34549005 http://dx.doi.org/10.1097/GOX.0000000000003814 |
Ejemplares similares
-
Formation of bilateral arteriovenous malformations
por: Shiraishi, Makoto, et al.
Publicado: (2022) -
Arteriovenous Malformation of the Head and Neck in a Hemodialysis Patient
por: Hattori, Yoshitsugu, et al.
Publicado: (2021) -
Somatic GJA4 gain-of-function mutation in orbital cavernous venous malformations
por: Hongo, Hiroki, et al.
Publicado: (2022) -
Safety of SARS-CoV-2 Vaccination in Patients with Vascular Malformations: Patient-Reported Adverse Vaccine Reactions
por: Shiraishi, Makoto, et al.
Publicado: (2023) -
Topical injection of sclerosant to treat cheek subcutaneous venous malformation resulting in blindness: a case report
por: Cui, Lihong, et al.
Publicado: (2023)